-
admin
Posts
UK Town Centres Market Report 2024 – Food & Grocery Sector Within Town Centres is Forecast to Grow at a CAGR of 1.9% between 2023 and 2028
Dublin, Nov. 19, 2024 (GLOBE NEWSWIRE) — The “Retail Locations Series: UK Town Centres Market 2023-2028” report has been added to ResearchAndMarkets.com’s offering. The UK...
Ocugen Announces Compelling Preliminary Data for OCU410—a Single Dose Novel Modifier Gene Therapy to Treat Geographic Atrophy Secondary to Dry Age-Related Macular Degeneration
MALVERN, Pa., Nov. 19, 2024 (GLOBE NEWSWIRE) — Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a biotechnology company focused on discovering, developing, and commercializing...
Achilles Therapeutics Receives Approval to Transfer to Nasdaq Capital Market
LONDON, Nov. 19, 2024 (GLOBE NEWSWIRE) — Achilles Therapeutics plc (NASDAQ: ACHL) today announced that on November 15, 2024, the Listing Qualifications department of the Nasdaq...
Oral Presentation at AASLD The Liver Meeting® 2024 Highlights Broad Clinical Activity of Chemomab’s CM-101 Across Multiple Biomarkers and Its Disease-Modifying Potential in Primary Sclerosing Cholangitis
—Clinical Data from Phase 2 SPRING Trial Shows that CM-101 Demonstrated Anti-Fibrotic, Anti-Inflammatory and Anti-Cholestatic Activity across Multiple Components of Primary Sclerosing Cholangitis— TEL AVIV, Israel, Nov....
Spineart Celebrates 100,000 Ti-Life Technology Cages Sold Worldwide
SPINEART CELEBRATES 100,000 TI-LIFE TECHNOLOGY CAGES SOLD WORLDWIDE Geneva, November 19, 2024 – Spineart, a leader in spine surgery innovation, today announces that it has...
Tiziana Life Sciences Announces Groundbreaking ALS Trial Grant Awarded by the ALS Association
NEW YORK, Nov. 19, 2024 (GLOBE NEWSWIRE) — Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies...
Medtronic reports second quarter fiscal 2025 financial results
Delivering on commitments, executing ahead of expectations, and raising guidance Innovation driving sustained growth across many franchises: TAVR, PFA, Leadless Pacemakers, Diabetes, Spine, and Neuromodulation...
Brii Bio Delivers First Head-to-Head Comparison of siRNA (Elebsiran) and PEG-IFNα Combination versus PEG-IFNα Alone at AASLD’s The Liver Meeting® 2024, Demonstrating Higher Loss of HBV Surface Antigen by Combining with siRNA
48-week end-of-treatment data from the ongoing Phase 2 ENSURE study clearly demonstrated the added benefits of elebsiran towards achieving a higher functional cure rate in combination...
Baijiayun Contributes to the “Urban and Rural School Community” Project, Empowering an Infinite Future for Smart Education
BEIJING, Nov. 19, 2024 /PRNewswire/ — Baijiayun Group Ltd (“Baijiayun” or the “Company”) (NASDAQ: RTC), a one-stop AI video solution provider, recently made contributions to...
Tongcheng Travel Posts Continued Growth and Increased Profitability in 2024 Q3
Core OTA Businesses Thrive Amid Robust DemandInternational Business Surges, Driving Long-term Success HONG KONG, Nov. 19, 2024 /PRNewswire/ — Tongcheng Travel Holdings Limited (“Tongcheng Travel”...
